Which Of The Following About Nosocomial Infections Is False Docx

0
59

The effect is to A) prevent mRNAribosome binding in eukaryotes. B) prevent peptide bond formation in prokaryotes. C) prevent polypeptide elongation in eukaryotes. D) prevent transcription in prokaryotes.

More recently, Ndt80p was shown to have a global effect on azole-resistance through is regulon which includes many genes involved in ergosterol metabolism . In 1981, the Food and Drug Administration approved a new antifungal, ketoconazole, developed by Heeres and his coworkers . This drug was the only antifungal available for treatment of systemic fungal infections caused by yeasts for the following ten years. However, there are several drawbacks to this drug. It is poorly absorbed when administered orally, and no ketoconazole form has ever been developed for intravenous injection.

When considering superficial fungal infections, it is essential to make an accurate diagnosis to prevent treatment failure. However, it is also necessary to treat the infection promptly to prevent the spread of infection and its sequelae. In particular, tinea capitis can lead to permanent baldness, which can have a serious psychosocial effect on children. Therefore, it is important to diagnose and treat tinea capitis early in its course. Providers should be aware that current doses of griseofulvin are effective and safe to use for tinea capitis in children. Ciclopirox is also used as a topical antifungal agent, but its mode of action remains poorly understood in fungi .

The polyoxins and nikkomycins are naturally produced antifungals that target chitin synthesis. As antifungal in vitro resistance poorly correlates with clinical outcome, better attention was needed to define parameters that produced reproducible and reliable intra- and interlaboratory results. For this purpose, two standardized methods for the testing of yeast and mould isolates are recognized as the gold standards for drug susceptibility testing [96–98]. These standardized approaches produce susceptibility results comparable between laboratories, which may help to establish breakpoints for antifungal agents (see [96–98] for details). Indeed, AmB is active against most yeasts and filamentous fungi.

Numerous of these point mutations identified in ERG11 were previously described, and their involvement in azole resistance was experimentally demonstrated for fungi such as Cryptococcus neoformans , C. In this species, it was demonstrated that the nature of the nucleotide mutation, and therefore, the nature of the amino acid substitution, influences the development of resistance to different azole agents [188–192]. Beyond targeting ergosterol in fungal cell membranes, there are a few antifungal drugs that on which of the following does the moment of inertia of an object depend? target other fungal structures . The echinocandins, including caspofungin, are a group of naturally produced antifungal compounds that block the synthesis of β(1→3) glucan found in fungal cell walls but not found in human cells. This drug class has the nickname “penicillin for fungi.” Caspofungin is used for the treatment of aspergillosis as well as systemic yeast infections. In the last decade, microorganisms are becoming drug resistant at a much faster rate than the rate of discovery of new drugs.

You can’t kill cancer cells without killing normal cells as well. Thus, using griseofulvin would be pointless unless you’re trying to kill cancer cells with griseofulvin’s mechanism of action too. Griseofulvin may decrease the blood level and hence efficacy of certain drugs, which are metabolised by cytochrome P450 3A4. These include oral contraceptives, coumarin anticoagulants and cyclosporin. Appropriate monitoring should be undertaken and dosage should be adjusted as necessary. Additional contraceptive precautions should be taken during griseofulvin treatment and for a month after stopping griseofulvin.

P. jirovecii is a yeast-like fungus with a life cycle similar to that of protozoans. As such, it was classified as a protozoan until the 1980s. It lives only in the lung tissue of infected persons and is transmitted from person to person, with many people exposed as children. Typically, P. jirovecii only causes pneumonia in immunocompromised individuals.

Acyclovir and its derivatives are frequently used for the treatment of herpes virus infections, including genital herpes, chickenpox, shingles, Epstein-Barr virus infections, and cytomegalovirus infections. Acyclovir can be administered either topically or systemically, depending on the infection. One possible side effect of its use includes nephrotoxicity. The drug adenine-arabinoside, marketed as vidarabine, is a synthetic analog to deoxyadenosine that has a mechanism of action similar to that of acyclovir.